Skip to main content
Show — Main navigation
Hide — Main navigation
Home
About
The Chair
Inquiry Team
Expert Groups
Inquiry Intermediaries
Core Participants
Legal Representatives
Inquiry Memorial
Financial Reports
Approach
Terms of reference
List of Issues
Statements of approach
Inquiry Principles
News
News
Newsletter Archive
Reports
The Inquiry Report
Additional Compensation Report
First Interim Report
Second Interim Report
Compensation Framework Study
Evidence
Evidence
Hearings Archive
Compensation
Support
Support and FAQs
NHS Psychological Support
Support Groups
Infected Blood Support Schemes
Hepatitis C Testing
Contact us
Search
Accessibility Tool
Zoom in
Zoom out
Reset
Contrast
Accessibility tool
Listen
Get in touch
Quick Exit
Subscribe to Search results
Search
Sort your search results
Relevance
Title
Changed
Dr Colvin mentioned that there were tiny amounts of an NHS small pool heat-treated concentrate available around the middle of 1984.
Published on:
30 September, 2024
At the NETR Haemophilia Working Party, it was suggested that until a positive test for AIDS and/or a vaccine is developed the use of blood products should be avoided. However this did not lead to any change of policy at The Royal London.
Published on:
30 September, 2024
Dr Colvin clarified that the statement he made that "there is no reason to spurn commercial concentrate" implied that he did not recommend that they don't buy commercial concentrate at all.
Published on:
30 September, 2024
Dr Colvin stated in his oral evidence "if you had abandoned all surgery except for the most life-saving and the home treatment programme and if you had cut back on dosage...the consequences of the temporary withdrawal of all blood products in the way that Dr Galbraith perfectly understandably recommended was a probable."
Published on:
30 September, 2024
Dr Colvin reported that there were 41 patients infected with HIV, of which 31 had severe Haemophilia A, 9 had moderate/mild Haemophilia A and 1 had Haemophilia B. He recalled three children who were infected with HIV from their treatment and one partner of a patient who was infected.
Published on:
30 September, 2024
By the mid 1970s a number of doctors held the view that non-A non-B Hepatitis was a mild or benign disease, which rested centrally on assertion and/or wishful thinking rather than evidence.
Published on:
07 August, 2024
The publication of "Percutaneous Liver Biopsy and Chronic Liver Disease in Haemophiliacs" in The Lancet meant that clinicians could no longer rely on the absence of overt or acute signs of hepatitis as a reliable indicator that non-A non-B Hepatitis would not develop.
Published on:
07 August, 2024
Dr Colvin in his evidence described an unwillingness for established clinicians to accept that Factor 8 might be flawed: he called the attitude "wishful thinking".
Published on:
08 August, 2024
Dr Brian Colvin described in his oral evidence some clinicians' belief that Non-A Non-B Hepatitis was benign as "wishful thinking".
Published on:
27 September, 2024
Dr Brian Colvin confirmed that, by 1975, the haemophilia treating community was aware that there was at least a possibility of chronic liver disease in haemophilia.
Published on:
27 September, 2024
Dr Brian Colvin told the Inquiry he treated very small children with cryoprecipitate until the mid 1980s.
Published on:
27 September, 2024
Dr Brian Colvin told the Inquiry that around 1982-1983 he was using a significant quantity of commercial concentrate in the hospital due to shortfall in NHS concentrate.
Published on:
27 September, 2024
Dr Winter held that due to the shortage Shortfalls were covered by the use of commercial concentrate, and cryoprecipitate was in limited use only for mild haemophilia or von Willebrand disorder, or occasionally for a child or rarely treated adult.
Published on:
27 September, 2024
With regards to treatment taking place at Guy's Hospital and Margate, Dr Winter held that patients diagnosed with moderate haemophilia may have also received commercial concentrates
Published on:
27 September, 2024
With regards to treatment taking place at Guy's Hospital and Margate, Dr Winter held that patients diagnosed with mild haemophilia may have also received commercial concentrates, in instances where DDAVP was proving ineffective.
Published on:
27 September, 2024
With regards to treatment taking place at Guy's Hospital and Margate, Dr Winter held that while children were prioritised for being treated with NHS products and that prophylactic treatment for children, there was a possibility that children received commercial concentrates too.
Published on:
27 September, 2024
With regards to treatment taking place at Guy's Hospital and Margate, Dr Winter held that with regards to the treatment of children, the general practice was that children were not given concentrate unless they absolutely needed it.
Published on:
27 September, 2024
Dr Winter took the post as director at the Haemophilia Centre in Margate in December 1983.
Published on:
27 September, 2024
Dr Winter held that at the Haemophilia Centre in Margate that around the time of 1983, there was a serious lack of funding.
Published on:
27 September, 2024
Dr Winter explained that no one approached Tooting hospital to help address the issue of cryoprecipitate supplies.
Published on:
27 September, 2024
Pagination
First page
First
Previous page
Previous
…
Page
2373
Page
2374
Page
2375
Page
2376
Current page
2377
Page
2378
Page
2379
Page
2380
Page
2381
…
Next page
Next
Last page
Last